Sun Pharma Acquires Organon for $11.75 Billion
Sun Pharmaceutical Industries has agreed to acquire Organon for $11.75 billion in cash, paying $14 per share. The deal is expected to significantly boost Sun Pharma's revenue and EBITDA, with the transaction projected to close in early 2027 after regulatory approvals.
Topics: Corporate Strategy Global Expansion Mergers and Acquisitions Pharmaceutical Industry